SpecCheck vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
SF optical industry B2B platform unifying eyewear ordering, tracking, and billing for eye care professionals; YC W23 $3.82M Initialized Capital seed targeting $68.3B US optical market fragmented across doctors, labs, and insurers.
About
SpecCheck is a San Francisco-based optical industry B2B platform — backed by Y Combinator (W23) with $3.82 million raised including a $3.7 million seed round led by Initialized Capital in October 2023 — providing eye care professionals and optical businesses with a unified prescription eyewear ordering, tracking, and billing system that connects optometrists, opticians, and optical labs in a single workflow to eliminate the manual coordination, phone calls, and paper-based processes that dominate the $68.3 billion US optical industry. Founded in 2023, SpecCheck addresses the fragmentation in optical dispensing workflow where prescriptions travel between eye doctors, dispensing opticians, and fulfillment labs through a mix of fax, phone, and disconnected software systems.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Also Compare
SpecCheck vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.